Myocardial Protection in Minimally Invasive Mitral Valve Surgery

January 15, 2020 updated by: Cristina Barbero, University of Turin, Italy

Endo-aortic Versus Trans-thoracic Clamping in Right Mini-thoracotomy Mitral Valve Repair: Outcome on Myocardial Pro-tection

Perfusion strategies and aortic clamping techniques for right mini-thoracotomy mitral valve (MV) surgery have evolved over time and remarkable short- and long-term results have been re-ported. However, some concerns have emerged about the adequacy of myocardial protection dur-ing the minimally invasive approach and about the role of aortic clamping strategies in this contest.

Aim of this study was to compare the efficacy, in terms of myocardial protection, of the en-do-aortic clamp (EAC) versus the trans-thoracic aortic clamp (TTC) in patients undergoing right mini-thoracotomy MV repair.

A single center, prospective observational study was performed between June 2014 to June 2018 on patients undergoing right mini-thoracotomy MV repair with retrograde arterial perfusion and EAC or TTC. The selection of one setting in respect to the other was patient orientated. Myocardial protection was assessed through creatinine kinase-myocardial band (CK-MB) and cardiac Troponin T (cTn-T) blood levels immediately after the surgical procedure and at 6, 12, and 24 hours and compared between the two groups.

Study Overview

Study Type

Observational

Enrollment (Actual)

116

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All comers at our Deparment with diagnosis of mitral valve disease with surgical indication for mitral valve repair through the right mini-thoracotomy approach and retrograde arterial perfusion.

Description

Inclusion Criteria:

  • Surgical indication for mitral valve repair.
  • Right mini-thoracotomy approach.
  • Retrograde arterial perfusion.

Exclusion Criteria:

  • Age more than 75 years.
  • Cardiac ejection fraction lower than 40%.
  • Previous cardiac surgery procedures for coronary artery bypass graft.
  • Any degree of coronary artery disease.
  • Severe peripheral vascular disease.
  • Concomitant procedures for atrial fibrillation ablation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
EAC
Patients undergoing surgery endo-aortic clamp.
In the firs group an endo-aortic clamp is used and in the second group an external clamp is used.
TTC
Patients undergoing surgery through trans-thoracic aortic clamp.
In the firs group an endo-aortic clamp is used and in the second group an external clamp is used.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cTn-T levels immediately after surgery
Time Frame: Immediately after surgery
Myocardial protection was assessed through cardiac Troponin T (cTn-T) blood levels and compared between the 2 groups of aortic clamping
Immediately after surgery
CK-MB levels immediately after surgery
Time Frame: Immediately after the surgery
Myocardial protection was assessed through creatinine kinase-myocardial band (CK-MB) blood levels after right mini-thoracotomy mitral valve surgery and compared between the 2 groups of aortic clamping
Immediately after the surgery
cTn-T levels 6h
Time Frame: hour 6 after surgery
Myocardial protection was assessed through cardiac Troponin T (cTn-T) blood levels and compared between the 2 groups of aortic clamping
hour 6 after surgery
CK-MB levels 6h
Time Frame: hour 6 after surgery
Myocardial protection was assessed through creatinine kinase-myocardial band (CK-MB) blood levels after right mini-thoracotomy mitral valve surgery and compared between the 2 groups of aortic clamping
hour 6 after surgery
cTn-T levels 12h
Time Frame: hour 12 after surgery
Myocardial protection was assessed through cardiac Troponin T (cTn-T) blood levels and compared between the 2 groups of aortic clamping
hour 12 after surgery
CK-MB levels 12h
Time Frame: hour 12 after surgery
(CK-MB) blood levels after right mini-thoracotomy mitral valve surgery and compared between the 2 groups of aortic clamping
hour 12 after surgery
cTn-T levels 24h
Time Frame: hour 24 after surgery
Myocardial protection was assessed through cardiac Troponin T (cTn-T) blood levels and compared between the 2 groups of aortic clamping
hour 24 after surgery
CK-MB levels 24h
Time Frame: hour 24 after surgery
Myocardial protection was assessed through cardiac Troponin T (cTn-T) blood levels and compared between the 2 groups of aortic clamping
hour 24 after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2014

Primary Completion (Actual)

June 30, 2018

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

January 5, 2020

First Submitted That Met QC Criteria

January 15, 2020

First Posted (Actual)

January 18, 2020

Study Record Updates

Last Update Posted (Actual)

January 18, 2020

Last Update Submitted That Met QC Criteria

January 15, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mitral Valve Prolapse

Clinical Trials on Aortic clamp

3
Subscribe